All‐cause mortality · patients with primary biliary cirrhosis.
It is very uncertain whether bisphosphonates changes all‐cause mortality compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Adverse events · patients with primary biliary cirrhosis.
It is very uncertain whether bisphosphonates changes adverse events compared with another bisphosphonate (very low certainty).
1 finding from 1 review
Lumbar spine bone mineral density (BMD) · patients with primary biliary cirrhosis.
1 finding from 1 review
Hip/femoral bone mineral density (BMD) · patients with primary biliary cirrhosis.
1 finding from 1 review
Procollagen type 1 N‐terminal propeptide (ng/mL) · patients with primary biliary cirrhosis.
1 finding from 1 review
The urinary amino telopeptides of collagen I (NTx) (nmol bone collagen equivalents /mmol creatinine) · patients with primary biliary cirrhosis.
1 finding from 1 review
Fracture · patients with primary biliary cirrhosis.
It is very uncertain whether bisphosphonates changes fractures compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Adverse events · patients with primary biliary cirrhosis.
It is very uncertain whether bisphosphonates changes adverse events compared with placebo or no intervention (very low certainty).
1 finding from 1 review
Lumbar spine bone mineral density (BMD) · patients with primary biliary cirrhosis.
1 finding from 1 review
Hip/femoral bone mineral density (BMD) · patients with primary biliary cirrhosis.
1 finding from 1 review
Serum osteocalcin (ng/ml) · patients with primary biliary cirrhosis.
1 finding from 1 review
The urinary amino telopeptides of collagen I (NTx) (nmol bone collagen equivalents /mmol creatinine) · patients with primary biliary cirrhosis.
1 finding from 1 review
All‐cause mortality · patients with primary biliary cirrhosis.
It is very uncertain whether bisphosphonates changes all‐cause mortality compared with another bisphosphonate (very low certainty).
1 finding from 1 review
Fracture · patients with primary biliary cirrhosis.
It is very uncertain whether bisphosphonates changes fractures compared with another bisphosphonate (very low certainty).
1 finding from 1 review